14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EVGN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evogene Ltd stock downgraded from Hold/Accumulate to Sell Candidate after Thursday trading session.
(Updated on May 02, 2024)

Sell candidate since May 02, 2024 PDF

The Evogene Ltd stock price fell by -1.41% on the last day (Thursday, 2nd May 2024) from $0.716 to $0.706. During the last trading day the stock fluctuated 6.34% from a day low at $0.688 to a day high of $0.732. The price has risen in 6 of the last 10 days and is up by 10.1% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -58 thousand shares and in total, 45 thousand shares were bought and sold for approximately $31.91 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.12% during the next 3 months and, with a 90% probability hold a price between $0.486 and $0.709 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EVGN Signals & Forecast

There are mixed signals in the stock today. The Evogene Ltd stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.731. On a fall, the stock will find some support from the short-term average at $0.675. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, May 01, 2024, and so far it has fallen -1.41%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Evogene Ltd stock

Evogene Ltd finds support from accumulated volume at $0.686 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0436 between high and low, or 6.34%. For the last week the stock has had daily average volatility of 7.31%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EVGN) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Evogene Ltd to open at $0.708, and during the day (based on 14 day Average True Range), to move between $0.658 and $0.753, which gives a possible trading interval of +/-$0.0478 (+/-6.77%) up or down from last closing price. If Evogene Ltd takes out the full calculated possible swing range there will be an estimated 13.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.686 (2.72%) than the resistance at $0.730 (3.47%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Evogene Ltd stock A Buy?

Evogene Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -3.245 Sell Candidate Downgraded

Predicted Opening Price for Evogene Ltd of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$0.708 ( 0.406%) $0.706

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EVGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.752 6.59 %
R2 0.735 4.23 %
R1 0.725 2.77 %
Current price: 0.706
Support S1 0.692 -1.95 %
S2 0.681 -3.41 %
S3 0.665 -5.77 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.771 9.21 %
R2 0.760 7.73 %
R1 0.730 3.47 %
Current price 0.706
Support S1 0.686 -2.72%
S2 0.641 -9.17%
S3 0.625 -11.40%

FAQ

What is the symbol for Evogene Ltd Stock and on which exchange is it traded?
The symbol for Evogene Ltd is EVGN and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Evogene Ltd Stock?
Evogene Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Evogene Ltd Stock?
Evogene Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Evogene Ltd Stock.

What's the current price of Evogene Ltd Stock?
As of the end of day on the May 02, 2024, the price of an Evogene Ltd (EVGN) share was $0.706.

What is the 52-week high and low for Evogene Ltd Stock?
The 52-week high for Evogene Ltd Stock is $1.44 and the 52-week low is $0.450.

What is the market capitalization of Evogene Ltd Stock?
As of the May 02, 2024, the market capitalization of Evogene Ltd is 35.688M.

When is the next earnings date for Evogene Ltd?
The upcoming earnings date for Evogene Ltd is May 16, 2024.
Click to get the best stock tips daily for free!

About Evogene Ltd

Evogene Ltd Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover... EVGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT